Canada markets closed

Blackstone Inc. (BX)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
118.40-1.92 (-1.60%)
At close: 04:00PM EDT
118.50 +0.10 (+0.08%)
After hours: 05:01PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close120.32
Open120.15
Bid0.00 x 900
Ask0.00 x 1000
Day's Range118.06 - 121.79
52 Week Range79.92 - 133.56
Volume3,911,999
Avg. Volume3,717,095
Market Cap144.178B
Beta (5Y Monthly)1.49
PE Ratio (TTM)64.35
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield3.35 (2.72%)
Ex-Dividend DateFeb 02, 2024
1y Target EstN/A
  • Business Wire

    Blackstone Real Estate to Take AIR Communities Private for Approximately $10 Billion

    NEW YORK & DENVER, April 08, 2024--Blackstone (NYSE: BX) and Apartment Income REIT Corp. (NYSE: AIRC) ("AIR Communities" or the "Company") today announced that they have entered into a definitive agreement under which Blackstone Real Estate Partners X ("Blackstone") will acquire all outstanding common shares of AIR Communities for $39.12 per share in an all-cash transaction valued at approximately $10 billion, including the assumption of debt.

  • PR Newswire

    Rexford Industrial Acquires Blackstone Industrial Assets in Combined $1 Billion Investment

    Rexford Industrial Realty, Inc. ("Rexford Industrial") (NYSE: REXR), a real estate investment trust focused on creating value by investing in and operating industrial properties located throughout infill Southern California, and Blackstone (NYSE: BX), today announced Rexford Industrial acquired approximately 3 million square feet of industrial properties pursuant to separate transactions with Blackstone Real Estate, including the Blackstone Property Partners strategy as well as Blackstone Real E

  • Business Wire

    Blackstone Life Sciences Announces Collaboration to Support Moderna’s Influenza Program

    NEW YORK, March 27, 2024--Blackstone (NYSE:BX) announced today a new collaboration with Moderna, Inc. (NASDAQ: MRNA, "Moderna") through a development and commercialization funding agreement where funds managed by Blackstone Life Sciences ("Blackstone") will provide up to $750 million to fund Moderna’s influenza ("flu") program.